The Drug Science Podcast
Professor David Nutt presents a rational, evidence-based approach to drug policy and drug use. The podcast explores the actual harms and potential benefits of various drugs, challenging myths surrounding classification and legislation. It examines the societal impact of poorly informed drug policy and advocates for using scientific evidence in public policy. This podcast is for anyone interested in understanding the scientific truth about drugs, free from political or moral concern.
Episodes
153. Psychedelics, Couples and Sex with Sarah Tilley
In this episode, we speak with Sarah Tilley, a couple’s therapy pioneer and the CEO and founder of Beautiful Space, a provider of psilocybin programmes for couples. She details how her own divorce led her to this work, emphasizing that issues between couples become emotionally taxing on their children, manifesting in poor mental health and wellbeing. Sarah discusses how she has seen psilo
152. Cocaine and Alcohol with David Hillier
In this episode of the Drug Science Podcast, Prof Nutt speaks with David Hillier, a journalist and the creator of the Substack WHAT ARE YOU ON. David Hillier has been writing about drug culture and mental health for 12 years and shares his journey into the drugs and harm reduction space, describing how a feature he wrote on The Loop cemented the topic as a broader journalistic focus. The
151. Francis Crick: From DNA to the Brain with Prof Matthew Cobb
In this episode, we speak to Prof Matthew Cobb, professor of zoology at the University of Manchester and author of Crick: A Mind in Motion, which profiles Francis Crick. Matthew shares insights into his own academic background in neurobiology and evolution, explaining the motivation behind his latest book. He delves into the collaborative approaches that fueled Crick's work and explains t
150. Synthetic Alcohol with David Orren
Join us in this episode of the Drug Science Podcast as Prof Jo Neill speaks with David Orren, CEO of GABA Labs, which has pioneered functional drinks with SENTIA Spirits. David recounts his initial communication with David Nutt and emphasises their shared mission to speak to younger generations’ desires for less harmful alternatives to alcohol. He touches on the neurological underpinnings
149. Psilocybin for Cancer with Dr Lauren Macdonald
In this episode, we speak to Dr Lauren Macdonald, a psychiatrist, psychedelic therapist, and group retreat facilitator. She details her path to psychedelics, in particular her cancer diagnosis that left her with existential dread that she felt fully dissipate only after a psychedelic experience. She goes on to discuss her interest in group retreats and treating existential distress. Befor
148. Sleep, Dreams and Sigmund Freud with Prof Mark Solms
Join us in this episode as Prof Nutt speaks to Prof Mark Solms, a leading expert on Freud and author of the new book The Only Cure. Mark details his early fascination with neuropsychology that led him to study the neurological underpinnings of sleep and dreams. He explains how some of his own research lent more credence to Freud’s claims and deepened his interest in psychoanalysis. Mark c
147. Rewarding the Human Mind with Dr Harriet De Wit
Join us in this episode as we speak to Dr Harriet de Witt, professor of psychiatry and neuropharmacology at the University of Chicago. She shares how she fell in love with the field, studying the animal model of self-administration, and how that work fed into her later research with human participants. As a leading expert on the pharmacology of MDMA, she explores the subtle differences be
146. Vaping in Schools with Hannah Dawes and Dr Rachael Andrews
Join us in this episode as we speak to Dr. Rachel Andrews, an addiction and harm reduction researcher at the University of Bath, and Hannah Dawes, a PSHE teacher and the creator of the podcast The Exchange. The conversation focuses on the prevalence of vaping in schools, particularly exploring the ways in which vapes have been marketed to children and the patterns of use in schools. Rache
145. Psychedelics, Power and the Price of Healing with Erica Rex
In this episode of the Drug Science Podcast, Prof Nutt speaks with Erica Rex, author of the book Seeing What is There, which explores the complex history of psychedelic therapy. She shares her own experiences with psychedelic-assisted therapy, while providing context on the guardrails that are necessary for these treatments to maximize benefits and minimize harms. Viewing psychedelics as
144. On Drugs: Philosophy, Consciousness and Sobriety with Justin Smith-Ruiu
In this episode, we’re joined by Justin Smith-Ruiu, a philosopher at Université Paris Cité and the author of On Drugs. He discusses his motivations behind the book, rooted in his early experiences with psychedelics and the many cultural roles he has seen them play across different contexts. As the conversation unfolds, Smith-Ruiu reflects on his decision to quit drinking in favor of psych
143. Psychedelics for Palliative care with Prof Robert Schoevers
Join us in this episode as we talk to Robert Schoevers, a professor of psychiatry at the University of Groningen and one of the pioneers of psychedelic-assisted therapy. He explains why human complexity led him to psychiatry, begoring discussing how his early psychedelic research into esketamine aimed to meet the unmet needs of treatment-resistant patients. Schoevers goes on to explore th
142. Animal Research and the Future of Depression with Prof Emma Robinson
Join us in this episode as we speak with Emma Robinson, a professor of psychopharmacology at the University of Bristol with extensive experience in animal research. She unpacks the regulations surrounding animal research, offering a scientist’s view on animal rights activism, ethical tension, and why this work remains essential. Robinson also delves into the emerging intersection of psych
141. Clubs, Raves, Drugs and Social Media with Simon Doherty
In this episode of the Drug Science Podcast, we talk to Simon Doherty, a journalist and content creator with a focus on harm reduction. He explores how reporting on electronic music and rave culture naturally led to his work on harm reduction. He goes on to dissect Talk to Frank and its flaws in providing accurate, evidence-based information. Finally, by comparing the unique landscape of
140. Which therapy works best for psychedelics? with Prof Sara Tai
Join us in this episode as we talk to Prof Sara Tai, a professor of clinical psychology at the University of Manchester and an NHS consultant clinical psychologist. Sara’s research is grounded in biopsychosocial frameworks, with a focus on understanding the mechanisms of change that underpin effective psychological therapies. She has extensive experience delivering therapy, and training o
139. Poppers with Adam Zmith
In this episode, we speak with Adam Zmith, podcast producer, writer, and author of Deep Sniff: A History of Poppers and Queer Futures. He describes his motivation behind writing the book, all before diving into the complex history of poppers. By speaking to the policing and regulation of poppers, Zmith explores broader struggles between the queer community and the government, in addition
138. Scottish Ambulance Service - Frontline Trauma with John, Joanne and Ryan
Join us in this episode as Prof Nutt speaks to John, Joanne, and Ryan of the Scottish Ambulance Service in Glasgow. They explore their backgrounds in the Service and how their work exposed them to challenging situations that caused severe detriment to their mental health. After describing the failings of traditional mental health support for emergency workers, they tell their story of tra
137. Cultural History of the Magic Mushroom with Dr Andy Letcher
In this episode of the Drug Science podcast, we speak to Dr Andy Letcher, a religious scholar and author of the book Shroom: the Cultural History of the Magic Mushroom. He explores his complimentary background in science and the humanities, depicting how this combination structured his thinking. Noting the religious potential of psychedelic experiences, Letcher links the spiritual with th
136. Parliamentary Office of Science and Technology with Jenny Chapman and Dr Stephen Naulls
Tune into the latest episode of the Drug Science Podcast, where we talk to Jenny Chapman and Dr. Stephen Naulls, researchers at the Parliamentary Office of Science and Technology (POST) and authors of ‘Psychedelic-assisted therapy for mental health: Policy considerations, a briefing for Parliament’ on the state of psychedelic research. They explore the remit of POST in highlighting object
135. Ethnomycology with Darren Le Baron
In this episode of the Drug Science Podcast, we speak with Darren Le Baron, an accomplished mycologist and educator. He discusses how his hardships from his upbringing in East London have informed his current work, where he uses horticulture to connect with children at risk of being drawn into crime. He transitions to explore his series Psychedelics in Africa, explaining some of the many
134. Tribe with Bruce Parry
Join us in this episode as we speak to Bruce Parry, the creator and star of the BBC series Tribe With Bruce Parry. He explains his sharp career change from a Royal Marine to an advocate for indigenous rights, where he’s developed a humble approach to learning from indigenous tribes, defined by listening and witnessing. He talks about his experiences of psychedelics in these contexts, name
133. Psychedelic Ethics with Dr Edward Jacobs and Sam Bloomfield
In this episode of the Drug Science Podcast, we speak with Sam Bloomfield, founder of PsyEdu, and Dr. Eddie Jacobs, the first person to complete a doctorate in psychedelic ethics. Drawing on their backgrounds in education and ethics, they explore why these perspectives are essential to the evolving field of psychedelics. They also discuss the role of trials, clinics, and retreats within t
132. The Fellowship of the River with Dr Joe Tafur
In this episode of the Drug Science Podcast, we meet with Dr. Joe Tafur, MD, an integrative Family Physician, curandero, author and speaker. He discusses his book, The Fellowship of the River, exploring the role of spiritual healing in modern healthcare. Within this episode. Tafur further delves into topics such as biological and psychological links to Generational trauma as well as the r
131. Scientists, Poets and Dissidents with Mike Jay
In this episode of the drug science Podcast, we meet with Mike Jay, author and 2024 Cheiron Book Prize winner who has written extensively on scientific and medical history with a special interest in Psychedelics. In this Podcast, he discusses with us his newest book, Free Radicals: How a Group of Romantic Experimenters Gave Birth to Psychedelic Science, which tells the story of early inve
130. Psychedelics and Women's Health with Dr Grace Blest-Hopley
Join us in the latest episode of the Drug Science Podcast, where we talk with Dr. Grace Blest-Hopley, Director of Research for Heroic Hearts Project UK, Chief Scientific Officer of NW PharmaTech, and founder and CEO of Hystelica. In the episode, she explore where psychedelic studies have largely ignored women’s physiology, particularly in failing to acknowledge and control for hormonal fl
129. Decolonising Plant Medicine with ICEERS
In this latest episode of the Drug Science Podcast, we talk with Natalia Rebollo and Jesús Alonso Olamendi of the International Center for Ethnobotanical Education, Research, and Service (ICEERS). They discuss the lasting legacy of colonialism in the psychedelic culture of indigenous communities, stressing the need for the sacredness of these substances to be uplifted and not commodified.
128. Former Doctor, Former Prisoner with Dr Tim Kerr
Tune in to the latest episode of the drug science podcast where David Nutt meets with Tim Kerr, a doctoral research student in Psychiatry at King’s College London. Tim discusses his journey from slowly falling into drug addiction and dealing whilst studying for his medical degree eventually leading to arrest and imprisonment. Tim shares how he used this time in an open prison to apply for
127. Psychedelic Therapy in the UK with Dr Laurie Higbed and Dr Owain Winfield
Join us in the latest episode of the Drug Science Podcast where David Nutt meets with Psychedelic psychotherapy experts Laurie Higbed and Owain Winfield to dive into how to use psychedelics in psychotherapy. In this episode, they discuss the different techniques used with different psychedelics for different conditions to optimise this type of therapy and why these differences are necessa
126. The body keeps the score with Dr Bessel van der Kolk
In this episode, we meet with Bessel van Der kolk, a trauma based psychiatrist, author, researcher and educator. Since the 1970s his research has been in the area of post-traumatic stress and he is the author of four books including best seller “the body keeps score”. Within this episode, he dives into what trauma is and different research into the impact trauma can have on the body and b
125. The 5-HT hypothesis of depression with Prof Philip Cowen and Dr Sameer Jauhar
In this episode of the Drug Science Podcast, David Nutt meets with psychopharmacologist Phil Cowen and Psychiatrist Sameer Jauhar to discuss the neuroscience behind and treatments for depression. Within the episode they touch on various neurotransmitters involved in depression as well as research studies into each of their impact, stigma around antidepressants and the role of psychedelic
124. The power of Medicine with Josh Dugdale
In this episode of the Drug Science podcast, we speak with Josh Dugdale of the Wasing Estate, described as a "mindful aristocrat." He shares his experiences with Ayahuasca in the Amazon and how they influenced his journey upon returning to the UK. Josh discusses the creation of a mindful and spiritual festival during the pandemic, its evolution over time, and its wider impact. He also exp
123. Memory, Movies and Psychedelics with Prof Ravi Das
Prof Ravi Das is a leading expert in psychopharmacology and cognitive neuroscience, with a career dedicated to understanding and developing innovative treatments for addiction and anxiety disorders. He completed his BSc in Psychology and MSc in Cognitive Neuroscience at University College London (UCL), followed by a PhD in Psychopharmacology at the UCL Clinical Psychopharmacology Unit. Pr
122. Street Drugs Discussions with Prof Chris Chandler and Dr James Morgan
Tune in to the latest episode of the drug science podcast where we meet with Dr James Morgan, Prof Chris Chandler and Prof Jo Neill, the founders of Street Drugs Discussions (SDD). They discuss the process which led to them founding SDD, a series of webinars featuring experts on drug policy and drugs featuring topics surrounding overdose prevention centres, trafficking, specific substance
121. What is Naturalistic Research? with Dr Matthew X. Lowe
A conversation between Prof David Nutt and research scientist Dr Matthew X. Lowe.Dr Matthew X. Lowe PhD is Director of Research for Realm of Caring and Executive Director for Unlimited Sciences, a not-for-profit, observational research organisation with a focus on cannabis and psychedelic use by underrepresented population groups and a toll-free info line providing evidence-based support
120. Ask David Anything
Tune in to the latest episode of the drug science podcast where Prof Nutt meets with several Drug Science Community members for a session of “Ask David Anything”. Together, they explore questions such as the use of cannabis as a psychoactive substance in psychedelic therapy and the latest developments in regulatory decisions on psychedelic-assisted psychotherapy. CannabisTHCCBDMDMAPsilo
119. American Politics vs Science with Zoe Cormier
In the latest episode of the Drug Science Podcast, David Nutt sits down with Zoe Cormier, author of ‘Sex, Drugs and Rock and Roll’. In this episode, Zoe draws upon her two great passions of music and science and how these lead to her interest around Drugs - she discusses the current landscape of drug policy, drawing upon similarities and differences between the UK, Canada, and the US. Sh
118. Psychotherapy with Andrew Feldmár
In this episode of the Drug Science Podcast, we hear from Andrew Feldmár, a psychotherapist with over 52 years of experience. He discusses his journey into psychotherapy, his departure from mainstream psychiatric and therapeutic practices rooted in the concept of mental illness, and his experiences with LSD. Feldmár also critiques various techniques used in contemporary psychedelic resear
117. Drugs and Music with Jon Hopkins
In this episode, Prof Neil and Dr Thurgur speak with electronic musician Jon Hopkins. Together, they explore the intersection of music, mental health, and psychedelics. Jon shares his personal journey, from his early love of music to his experiments with electronic sounds as well as discussing how experiences with meditation and psychedelics have profoundly influenced his music, shaping a
116. Reducing drug harms in the UK with Dr Gillian Shorter and Prof Alex Stevens
In this episode, Prof Nutt meets with Prof Alex Stevens, researcher in drug policy, treatment and harm reduction and Gillian Shorter, a researcher into the health and wellbeing of people who use alcohol and drugs. In this episode they discuss harm reduction strategies in the UK. They delve into the root causes of the stigma surrounding substance use disorders and explore the effectiveness
115. Six years of medical cannabis in the UK with Dr Leon Barron, Dr Callie Seaman and Michael Sassano
What is the UK medical cannabis industry looking like in 2024?We are 6 years on from legalisation of cannabis-based medical products in the UK and although many patients have now been able to access these products, many others are still struggling to get access. In this episode of the Drug Science podcast, Prof. David Nutt is joined by three leading experts in cannabis science and the evo
114. Chemsex with Darren Murphy
In this episode, we meet with Darren Murphy, a Chemsex Specialist Practitioner at Forward Leeds, to discuss chemsex, addiction, as well as addressing the link with the LGBTQ+ community. Darren shares his personal journey, navigating the challenges of drug addiction and everything which came with it. Realising the limited support available for people engaging in chemsex, Darren shares how
113. Psychiatrists and Curanderos with Dr Simon Ruffell
In this episode, we sit down with Dr. Simon Ruffell, a psychiatrist and ayahuasca researcher with extensive experience working with Indigenous communities in the Amazon Basin. He discusses the potential of Indigenous medicines to complement Western psychiatric care and reduce relapse rates. Dr. Ruffell compares Western and Indigenous approaches to using spiritual plants, addressing the o
112. Parties, drugs and young people with Dr Karenza Moore
In this episode, we meet with Dr Karenza Moore as she discusses changes in drug trends in the UK, focusing on the motivations, risks, and patterns of drug use, particularly among young people. Karenza identifies trends in drug use, including the impact of the lockdown on substance abuse. She also examines various drug trends within dance music culture, which leads to a discussion of safer
111. OCD and Psychedelics with Rose Cartwright
In this episode, Prof Nutt meets with Rose Cartwright as she discusses the impact of psychedelics on her Obsessive-compulsive disorder (OCD). She reflects on some of the common misconceptions around OCD as well as the impact diagnosis and traditional treatment had on her life. Throughout the episode, she reflects on her own psychedelic experiences, mistakes made along the way and the step
110. Ancient Wisdom in the Modern World with Satya
In this episode, we meet with Satya, a consciousness activist, who has been entirely dedicated to the expansion and evolution of human consciousness for 15 years. Throughout this time, she has facilitated retreats for over 63,000 people around the world, with profound processes of transformation. Satya is the founder of Working With Satya and of the Awareness Facilitator School, that is c
109. Prisons and Drugs with Prof Karen Duke and Prof Susanne MacGregor
In this episode, we meet with Prof Susanne MacGregor and Prof Karen Duke to explore the issues surrounding drug use in prisons. They discuss the ways vulnerable inmates can be targeted by gangs, as well as how various aspects of the prison environment can increase the potential harms of psychoactive substances. The risk matrix: Drug-related deaths in prisons in England and Wales, 2015–20
108. Psychedelic Education in the UK with Dr Duncan Still
In this episode, David Nutt meets with Dr Duncan Still, a GP with significant interest in integrative medicine. He highlights the importance of adopting a holistic approach when providing support for patients and connecting traditional medicine with modern medicine as opposed to discounting it. Duncan explains how this holistic and integrative approach led to him becoming involved in psyc
107. Kava with Dr Apo Aporosa
In this episode we meet with Dr Apo AporosaHe discusses his unconventional route to his PhD, having not finished school and joined the Army followed by the police only to break into academia at a masters level and continuing studies from there. Apo talks about his PTSD diagnosis and his subsequent journey with Kava, a spiritual drink consumed in Fijian culture. He discusses the affect thi
106. The Microdot Gang with Kate Hayes
In this episode, Kate Hayes reflects on her experiences with the LSD Microdot Gang, drawing upon her interactions and experiences with Dr. Christine Bott and Richard Kemp. She addresses Richard and Christine’s aspiration to bring about positive change in the world using LSD which led to their eventual arrest following involvement in an LSD production and distribution network. At the time,
105. MDMA medicalisation in the US with Dr Julie Holland
In this episode we meet with Dr Julie Holland. She discussed how MDMA influenced her career and inspired her to investigate its therapeutic potential. Controversially, she has investigated the effect of MDMA in schizophrenia and its potential in preventing paranoia and inhibiting auditory hallucinations during its effects. Dr Holland touches upon debate subjects such as the likelihood of
104. Psychedelics in New Zealand with Dr Suresh Muthukumaraswamy
In this episode, we meet with Dr. Suresh Muthukumaraswamy, an Associate Professor of Pharmacy in Auckland. Dr. Muthukumaraswamy discusses his early research, exploring the functional connectivity of substances like DMT and Ketamine. He proceeds to share insights into his breakthrough realisation regarding the disparity between the self-reported success of microdosing outside the lab sett
103. Neuroimaging with Prof Mitul Mehta
Professor Mitul Mehta explains how his studies in neuroscience and the role of dopamine in learning and memory led to his own career in neuroimaging. He offers an overview of what neuroimaging entails and how these scans can contribute to the advancement of research. Drawing from his latest research centred around Schizophrenia, Mitul delves into our understanding of drug interactions wit
102. MDMA and the Octopus with Dr Gül Dölen
In this episode, Prof Neill and Dr Thurgur meet with Dr Gül Dölen, a neuroscientist known for studying social behaviour and psychedelic drugs. Together, they explore the role of critical periods in trauma and mental health; following the potential of Psychedelics in reopening critical periods which were previously thought to be closed, they debate whether a critical period closing is ever
101. LSD, Nazis and the CIA with Norman Ohler
In this episode, Prof Nutt meets with German author Norman Ohler as he speaks about his new book “Tripped” which addresses drug use in post-Nazi Germany. Ohler shares how a secret history held back therapeutic research of psychedelic drugs for decades and eventually Nazi policies became part of the foundation of America’s War on Drugs. Ohler discusses theories as to why substances have be
100. 100 Years of the Maudsley Hospital with Dr James Rucker
On the 100th Episode of the Drug Science podcast, Prof David Nutt meets with Dr James Rucker to celebrate the 100th anniversary of Maudsley Hospital. James shares his experiences as one of the first clinicians in a psychedelic study hosted by David Nutt before explaining his own personal journey into psychedelic research. Starting from a PhD in Genetics, James’ interest shifted, becoming
99. Anyone's Child with Anne-Marie Cockburn and Jane Slater
In this episode, we meet with Jane Slater, co-founder of Anyone’s Child and Anne Marie, a mother who tragically lost her child, Martha, to an accidental overdose. Anne and Jane discuss the consequences of drug policy failures and the need for safe drug use education, drawing in on Anne’s personal journey. She discusses the pain of losing a loved one to a preventable drug related death and
98. The Merseyside Experiment with John Marks
In this week's episode, we feature John Marks, an Addiction Psychologist who spearheaded the Merseyside experiment in northwest England from 1982 to 1995. Throughout this 13-year period, Marks fearlessly operated clinics in Liverpool, basing his practice on the long-term maintenance prescribing of opiates to opiate users.The high media profile of his work, set against the backdrop of febr
97. 5-MeO-DMT with Patrick Cox
In this episode, we meet with Patrick Cox, a fashion designer with a background collaborating with Vivienne Westwood. Patrick shares his personal journey from his lifestyle in fashion, led to confronting deep-seated intergenerational trauma. Patrick opens up about undertaking the highly secretive Hoffman Process, and the transformative impact this had on him. From there, he further recoun
96. Ayahuasca: Before and After with Evgeny Lebedev
In this episode, David Nutt meets with Evgeny Lebedev, owner of the Independent and Evening Standard newspaper. Lebedev shares his transformative journey during his first Ayahuasca ceremony in Costa Rica. Throughout the episode, Lebedev not only shares insight into the ceremony's practices but also describes each personal ayahuasca experience and the themes that tied them together. He hig
95. Psilocybin for Obsessive-Compulsive Disorder with Sorcha O'Connor
In the last episode of our live series, David meets with Sorcha as she explains her ongoing research into using low dose psilocybin in treating OCD. She discusses the pre-existing treatment paradigms for OCD and highlights the potential benefits of Psilocybin assisted psychotherapy in future treatment. She overviews her current study and the theories behind it. SchizophreniaOCDPsilocybi
94. Can psychedelics help us improve our romantic relationships? with Tommaso Barba
Tomasso discusses his journey on how he became interested in neuroscience and how that lead to him becoming involved with the UK's leading Psychedelic Research Centre. He discusses the potential of psychedelics in promoting positive sexual wellbeing and healthy relationships. He discusses research into the advantages of using psilocybin as an alternative to SSRI’s as well as the potential
93. Psilocybin for Anorexia Nervosa with Hannah Douglass
David talks to Hannah, a 3rd year PhD student as she discusses her research into using psychedelics to treat eating disorders. She highlights how following personal experiences she came to find current treatment methods for anorexia were not sufficient and instead began conducting her own research with Imperial College London to investigate psilocybin-assisted psychotherapy to treat eatin
92. Psilocybin for Gambling Addiction with Dr Rayyan Zafar
In the first of our LIVE Psilocybin Series, David Nutt speaks to Rayyan Zafar a final year PhD student at Imperial College London. Rayyan discusses his interest of the connection between the mind and the brain and how it led to his research into using psychedelics to treat addiction. Rayyan delves into various behavioural and neurochemical theories into why dependency occurs and highligh
91. The Psychedelic Industry with Josh Hardman
In this episode, Josh Hardman, the founder of Psychedelic Alpha, explores the multitude of challenges currently being encountered by the psychedelic industry. He engages in discussions regarding the progress of decriminalisation and legalisation initiatives, upcoming clinical trial milestones, and delves into the current state and the potential evolution of the Psychedelic industry. Psych
90. Investing in Psychedelics with Dustin Robinson
In this episode, Prof Jo Neill and Dr Hannah Thurgur sit down with Dustin Robinson, the visionary founding partner of Mr. Cannabis Law and a co-founder of Mr. Psychedelics Law. These law firms possess the expertise needed to navigate the intricate and strictly regulated realms of cannabis and psychedelics, addressing a wide range of legal and business challenges within these unique indust
89. David Vs David with Dr David Erritzoe
Recorded live from the launch event of David Nutt's latest book, "Psychedelics: The Revolutionary Drugs That Could Change Your Life – a guide from the expert," in this episode Dr. David Erritzoee and David Nutt engage in a discussion about Psychedelics. During the conversation, David Nutt provides valuable insights into the research that initially ignited his interest in Psychedelics and
88. Psychonauts with Mike Jay
In this episode, Mike Jay explores the contents of his latest book titled "Psychonaut," which offers a thought-provoking and unique account of the scientists, writers, artists, and philosophers who engaged in drug exploration to uncover the enigmatic realms of the mind. The podcast delves into the historical perspective of psychedelics, shedding light on the evolving societal perceptions
87. Mental Health in Academia with Dr Meg Spriggs
In this episode, Meg Spriggs shares her firsthand experience dealing with the challenges mental health while pursuing her studies in academia. She candidly talks about the difficulties she faced with anorexia and mood disorders which led to her investigating the potential of psilocybin for treating Anorexia Nervosa. During the discussion, Meg reveals the shame she felt was associated with
86. Diamorphine Assisted Treatment with Danny Ahmed
In this episode, Jo Neill, and Hannah Thurgur are joined by Danny Ahmed, a highly experienced Registered Mental Health Nurse and Integrated Psychotherapist with over two decades of expertise. Together, they delve into a comprehensive discussion on a variety of harm reduction techniques. Throughout the episode, Danny shares his wealth of insights into the complex world of harm reduction. T
85. MDMA, Ketamine and Cannabis with Prof Valerie Curran
In this episode, Professr Valerie Curran, discusses the psychological effects of drugs that act on the human brain. Valerie Curren holds the position of Professorial Fellow in the Neuroscience of Addiction and Mental Health Program at ACU's Healthy Brain and Mind Research Centre. She has an esteemed background as an Emeritus Professor of Psychopharmacology at University College London (UC
84. Will DMT be a medicine in the UK? with Dr Carol Routledge
Join us for an insightful episode featuring Dr. Carol Routledge, a distinguished senior scientist and the Chief Medical and Scientific Officer at Small Pharma Labs. Dr. Routledge takes us on a journey through her remarkable career path that ultimately led her to work at Small Pharma. With a wealth of experience in both preclinical and clinical settings, she has delved into psychiatric and
83. Australia medicalises MDMA and psilocybin with Peter Hunt
In this episode, Peter Hunt discusses the journey which led himself and his wife co-founding Mind Medicine in Australia. Mind Medicine work to alleviate the suffering and suicides caused by mental illness in Australia through expanding the treatment options available to medical practitioners and patients, particularly through the establishment of safe and effective psychedelic-assisted th
82. Psychedelics in Europe with Tadeusz Hawrot and Frédéric Destrebecq
This weeks Podcast features Frédéric Destrebecq and Tadeusz Hawrot as they discuss the latest developments in research and clinical development with psychedelics in Europe.Frédéric Destrebecq is the Executive Director of the European Brain Council (EBC), a non-profit organization based in Brussels, Belgium. The EBC is a network of organizations and individuals dedicated to promoting brain
81. Head Injury, Professional Rugby and Psychedelics with Rory Lamont
This weeks podcast features Rory Lamont, a former professional Rugby Union player, as he discusses his experiences discovering the transformative healing potential of plant medicines such as Iboga and Ayahuasca.During the 2012 Six Nations tournament, while playing for Scotland, Rory suffered a severe leg break that brought his career to an end. Subsequently, he faced a debilitating health
80. Cannabis for Epilepsy with Dr Evan Lewis
In this week's episode of the Drug Science Podcast, Prof Nutt and Dr Thurgur are joined by Dr Evan Lewis of Numinus! Dr. Evan Lewis is a Paediatric Neurologist and Clinical Neurophysiologist with expertise in epilepsy, epilepsy surgery, electroencephalography (EEG), tele-neurology and medical cannabis for the treatment of neurologic disorders. He is the director of the Neurology Centre of
79. Smoking vs Vaping with Dr Alex Wodak
In this week’s episode, join Professor David Nutt as he engages in a thought-provoking conversation with Dr Alex Wodak, an internationally renowned authority on harm reduction and the esteemed president of the Australian Drug Law Reform Foundation. With a rich background as the former director of the Alcohol and Drug Service at St Vincent's Hospital in Sydney, Australia, Dr Wodak has been
78. Are Psychedelics Anti-inflammatory? with Dr Charles Nichols
Join us on this enlightening episode of the Drug Science podcast as we delve into the fascinating world of serotonergic pathways and their potential applications in treating psychiatric disorders and combating inflammation. Our special guest, Charles Nichols, a distinguished professor of pharmacology at LSU New Orleans, shares his groundbreaking research on the psychedelic 5-HT2A serotoni
77. Is Depression Evolutionary? with Dr Charles Raison
Is depression evolutionary? Is inflammation good or bad? Can sleep be bad for you? Tune in to find out. Depression is a complex and debilitating mental health disorder that affects millions of people worldwide. Despite the prevalence of depression, its causes and origins are still not entirely understood. In this episode of the Drug Science Podcast, we explore the evolutionary perspectiv
76. What is Decriminalisation? with Kassandra Frederique
Are you curious about the impact of drug policies on marginalized communities? Then tune in to this week's episode of our podcast! Our guest, Kassandra Frederique, the Executive Director of the Drug Policy Alliance, joins Dr. Hannah Thurgur to discuss the impact of drug policies on Black, Latino, Indigenous, immigrant, and LGBTQ communities. You'll also discover how the Drug Policy Allian
T21 - Medical Cannabis bonus episode
T21 (formerly Project Twenty21) is a pioneering medical cannabis registry launched in the United Kingdom in 2019. It aims to create the UK's largest body of evidence for the effectiveness and tolerability of medical cannabis in treating a range of conditions.T21 focuses on patients with conditions that can be treated with medical cannabis such as chronic pain, anxiety conditions, epilepsy
75. DMT for Depression with Dr Graham Campbell
Are you curious about the potential therapeutic benefits of psychedelic-assisted therapy? Tune in to this week's episode of our podcast, where we have a fascinating conversation with Dr. Graham Campbell, a renowned consultant psychiatrist and researcher in the field.Drawing from his extensive experience in both psychedelic research and clinical work, Dr. Campbell shares his insights on a
Recommended
The Profitable Baker Podcast
The Non-Billable Podcast
CEO Stories: Conversations with Greater Birmingham business leaders
InsideAIR
Sami Hamdi
The Lancet Voice
English L'Abri
Ajahn Amaro Podcast by Amaravati
The Sheriff Show with Lewis Capaldi 2.0
Triathlon Mockery
The Snooker Hall Podcast
Snooker Club | WST’s Official Podcast
